Poster Presentation 45th Lorne Genome Conference 2024

Epigenetic and transcriptional control of female-biased autoimmune disorders   (#156)

Ksenia Skvortsova 1 2 , Etienne Masle-Farquhar 1 , Matt Field 3 , Luu Phuc-Loi 4 , Dan Suan 1 5 , Clara Young 1 , Tim Peters 1 , Manu Singh 1 , Susan Clark 1 2
  1. Garvan Institute of Medical Research, Sydney, NSW, Australia
  2. St Vincent's Clinical School, University of NSW, Sydney, NSW, Australia
  3. James Cook University, Cairns, Queensland, Australia
  4. Pacific Informatics, Ho Chi Minh City, Vietnam
  5. Clinical Immunology and Immunopathology, Westmead Hospital,, Sydney, NSW, Australia

80% of patients with autoimmune disease are women. Emerging evidence suggests that aberrant re-activation of immune genes on the second, inactive, X chromosome in female B cells might play a role in the pathogenesis of female-biased autoimmune diseases. However, the extent of epigenetic and transcriptomic landscape perturbation and the mechanisms behind aberrant X chromosome re-activation in female patients with autoimmunity remain completely unknown.

 

To address this outstanding question, we employed allele-specific single cell full length RNA sequencing (smart-seq2) in combination with flow cytometry to study X chromosome inactivation dynamics during normal lymphopoiesis in bone marrow as well as in rare auto-reactive B cells isolated from peripheral blood of patients with systemic lupus erythematosus (SLE).  

 

Preliminary data analysis revealed that X-linked genes, upregulated in B cells isolated from female patients with SLE, are long non-coding RNA XIST-dependent, suggesting that in SLE there is a dysregulation of XIST-mediated silencing of inactive X chromosome. Additionally, auto-reactive memory B cells that display partial re-activation of the inactive X chromosome, were enriched among CD21-/low memory B cells.

 

We are now performing smart-seq2 on a larger number of auto-reactive B cells isolated from different patients in order to find common pathways mis-regulated in these cells, which led to aberrant re-activation of the second, inactive X chromosome. This will greatly advance our understanding of gene regulation governing autoimmune disease pathogenesis and shed light on sex-based differences in autoimmunity.